Evaluation of the efficacy of cervical pessary combined with vaginal progesterone in women with a short cervix and additional risk factors for preterm delivery

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3120400 28 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Evaluation of the efficacy of cervical pessary combined with vaginal progesterone in women with a short cervix and additional risk factors for preterm delivery
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Objective: The aim of this study was to examine the efficacy of a combined management with cervical pessary and vaginal progesterone of women with a singleton pregnancy and a short cervix in both low and high risk-cases based on their previous obstetrical history and maternal factors. Study design: This was a prospective cohort study of women with a singleton pregnancy and a sonographically detected mid-trimester cervical length ≤ 25 mm. The high-risk group consisted of women with a history of a previous spontaneous preterm birth (PB), or a second-trimester miscarriage, or a loop electrosurgical excision procedure of the cervix (LEEP) while the low-risk group of women without such a history. All women were managed with cervical pessary and daily vaginal administration of 200 mg of progesterone. The primary outcome measure was spontaneous delivery before 34 weeks (238 days) of gestation. Results: One hundred ninety-six cases with a CL ≤ 25 mm were detected during the study period. Fifty-two women declined to participate in the study. The remaining 144 women were divided into two groups based on the presence (n = 44) or absence (n = 100) of specific risk factors for PB. The rate of PTB < 34 weeks was similar in both low and high-risk pregnancies while a significantly higher rate of sPTB < 37 weeks was found in women with high-risk pregnancies (p =.005). Conclusion: The combined treatment of cervical pessary and vaginal progesterone has a similar influence on preterm delivery rate < 34 weeks, in both low and high-risk women, with a mid-trimester short cervix. © 2019 Informa UK Limited, trading as Taylor & Francis Group.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Daskalakis, G.
Zacharakis, D.
Pergialiotis, V.
Kalmantis, K.
Theodora, M.
Siristatidis, C.
Antsaklis, P.
Antsaklis, A.
Loutradis, D.
Περιοδικό:
Journal of Maternal-Fetal and Neonatal Medicine
Εκδότης:
Taylor and Francis Ltd.
Τόμος:
34
Αριθμός / τεύχος:
8
Σελίδες:
1277-1283
Λέξεις-κλειδιά:
progesterone; progesterone, adult; Article; cervical length; clinical effectiveness; clinical trial; cohort analysis; drug effect; echography; electrosurgery; female; gestational age; high risk population; human; low risk population; major clinical study; medical history; outcome assessment; patient participation; premature labor; priority journal; prospective study; risk factor; second trimester pregnancy; spontaneous abortion; treatment outcome; diagnostic imaging; intravaginal drug administration; newborn; pregnancy; prematurity; uterine cervix; vagina pessary, Administration, Intravaginal; Cervix Uteri; Female; Humans; Infant, Newborn; Pessaries; Pregnancy; Premature Birth; Progesterone; Prospective Studies; Risk Factors
Επίσημο URL (Εκδότης):
DOI:
10.1080/14767058.2019.1634686
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.